Anterix Inc (ATEX) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q1 FY2027, filed Aug 11, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ATEX SEC filings page.
Anterix Inc (ATEX) reported $7.0M in revenue over the twelve months to Jun 30, 2026, up 18.9% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Anterix’s dominant mechanic is a sharp earnings swing that remains largely disconnected from operating cash generation.
In FY2026, reported operating income reached$93.9M on revenue of$6.5M , yet net income was only$90.6K and operating cash flow was$5.5M . Operating cash flow nearly equaled free cash flow because capital expenditures were just$31K , so the limited cash corroboration is not explained by reinvestment intensity.
SG&A and R&D fell from
Debt-to-equity declined from 1.1x in FY2025 to 0.8x in FY2026, indicating a less leveraged posture even as reported earnings swung sharply. The current ratio rose from 2.2x to 3.3x, indicating improved short-term coverage but not independently proving durable cash strength.
Financial Health Signals
Scored against emerging companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Anterix Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Anterix Inc held $98.5M in cash, cash equivalents and investments at the end of fiscal year 2026, and its operations generated $5.5M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Anterix Inc scores 85/100 among other emerging companies.
Anterix Inc had 19M shares outstanding at the end of fiscal year 2026, against 19M in fiscal year 2025. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and Anterix Inc scores 63/100 among other emerging companies.
Not available for Anterix Inc, and counted as zero in the overall score.
Anterix Inc reported revenue of $6.5M in fiscal year 2026, against $6.0M in fiscal year 2025. Revenue Progress ranks emerging companies on the three-year path of that line, and Anterix Inc scores 68/100 among other emerging companies.
Not available for Anterix Inc, and counted as zero in the overall score.
Anterix Inc's cash, cash equivalents and investments came to $98.5M at the end of fiscal year 2026, against $202.9M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Anterix Inc scores 43/100 among other emerging companies.
Anterix Inc scores 4.85, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($1.6B) relative to total liabilities ($202.9M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Anterix Inc passes 5 of 7 computable financial strength tests (2 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
Anterix Inc reported $91K of net income while generating $5.5M in operating cash flow. The ratio between the two is outside the range this page publishes as a per-dollar figure, so both figures are given instead.
Key Financial Metrics
Earnings & Revenue
Anterix Inc generated $2.0M in revenue in Q1 2027. This represents an increase of 38.1% from the same quarter a year earlier. It is unchanged from the prior quarter.
Anterix Inc's EBITDA was -$145K in Q1 2027, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 100.6% from the same quarter a year earlier. Against the prior quarter it is down 100.7%.
Anterix Inc reported $240K in net income in Q1 2027. This represents a decrease of 99.0% from the same quarter a year earlier. Against the prior quarter it is up 100.3%.
Anterix Inc earned $0.01 per diluted share (EPS) in Q1 2027. This represents a decrease of 99.3% from the same quarter a year earlier. Against the prior quarter it is down 99.0%.
Cash & Balance Sheet
Anterix Inc generated $2.0M in free cash flow in Q1 2027, representing cash available after capex. This represents an increase of 164.0% from the same quarter a year earlier. Against the prior quarter it is down 87.0%.
Anterix Inc held $116.0M in cash as of Q1 2027; long-term debt is not reported for that period.
Not reported for Q1 2027.
Margins & Returns
Anterix Inc's operating margin was -12.6% in Q1 2027, reflecting core business profitability. No change is given against Q1 2026: its reported ratio is above 100.0% of revenue, so it does not read as a share of revenue.
Anterix Inc's net profit margin was 12.3% in Q1 2027, showing the share of revenue converted to profit. No change is given against Q1 2026: its reported ratio is above 100.0% of revenue, so it does not read as a share of revenue.
Anterix Inc's ROE was 0.1% in Q1 2027, measuring profit generated per dollar of shareholder equity. This is down 13.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 27.5 percentage points.
Not reported for Q1 2027.
Capital Allocation
Anterix Inc invested $1.2M in research and development in Q1 2027. This represents an increase of 8.9% from the same quarter a year earlier. Against the prior quarter it is down 3.7%.
Anterix Inc invested $36K in capex in Q1 2027, funding long-term assets and infrastructure. Against the prior quarter it is up 63.6%.
Not reported for Q1 2027.
ATEX Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-Q | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.0M+38.1% | $2.0M+41.0% | $1.6M+0.4% | $1.6M+0.1% | $1.4M-7.0% | $1.4M+10.2% | $1.6M+23.2% | $1.6M+47.4% |
| R&D Expenses | $1.2M+8.9% | $1.3M+16.3% | $1.1M-1.4% | $1.2M-31.8% | $1.1M-36.0% | $1.1M-51.4% | $1.1M-9.5% | $1.8M+54.8% |
| SG&A Expenses | $9.6M-7.9% | $8.6M-7.2% | $8.7M-5.9% | $8.4M-26.3% | $10.4M-18.7% | $9.2M-3.9% | $9.2M-18.2% | $11.4M-4.3% |
| Operating Income | -$246K-101.1% | $19.8M+111.1% | -$9.1M-228.9% | $60.7M+562.1% | $22.5M+249.8% | $9.4M+189.4% | $7.0M+625.7% | -$13.1M-681.2% |
| EBITDA | -$145K-100.6% | $19.9M+110.5% | -$9.0M-224.9% | $60.8M+568.5% | $22.6M+252.4% | $9.5M+191.8% | $7.2M+514.7% | -$13.0M-625.9% |
| Income Tax | $374K+116.6% | $1.9M+176.3% | -$2.1M-776.9% | $7.5M+3168.7% | -$2.3M-284.7% | $674K+618.5% | -$234K-117.5% | $230K-64.3% |
| Net Income | $240K-99.0% | -$72.0M-450.2% | -$6.6M-185.6% | $53.5M+519.4% | $25.2M+262.2% | $20.6M+7141.0% | $7.7M+2250.6% | -$12.8M-715.8% |
| EPS (Basic) | $0.01-99.3% | $0.99+98.0% | -$0.35-185.4% | $2.86+514.5% | $1.35+260.7% | $0.50+198.0% | $0.41+1950.0% | -$0.69-727.3% |
| EPS (Diluted) | $0.01-99.3% | $0.98+96.0% | -$0.35-185.4% | $2.86+514.5% | $1.35+260.7% | $0.50 | $0.41+1950.0% | -$0.69-727.3% |
| Diluted Shares (Avg) | 20M+4.9% | N/A | 19M-0.5% | 19M+0.6% | 19M+1.2% | N/A | 19M-0.7% | 19M-2.7% |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, Interest Expense.
ATEX Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-Q | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $497.9M+38.5% | $465.2M+39.7% | $417.0M+27.6% | $420.4M+32.5% | $359.6M+12.0% | $333.1M+2.5% | $326.7M+1.8% | $317.2M+13.3% |
| Current Assets | $153.1M+176.5% | $120.0M+97.5% | $50.1M+24.3% | $58.8M+3.6% | $55.4M-15.7% | $60.8M-16.8% | $40.3M-48.3% | $56.8M-8.6% |
| Cash & Equivalents | $116.0M+180.0% | $98.5M+108.0% | $29.5M+2.6% | $39.1M-9.4% | $41.4M-19.9% | $47.4M-21.8% | $28.8M-53.6% | $43.1M-11.1% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $212.1M+21.4% | $202.9M+14.9% | $181.1M-0.5% | $180.0M+1.0% | $174.8M+1.4% | $176.5M+7.7% | $181.9M+22.4% | $178.2M+71.7% |
| Current Liabilities | $31.5M-12.2% | $36.0M+32.3% | $36.0M+47.6% | $34.6M+119.0% | $35.9M+117.6% | $27.2M+51.5% | $24.4M+41.4% | $15.8M+3.3% |
| Non-Current Liabilities | $180.6M+30.1% | $166.9M+11.8% | $145.0M-7.9% | $145.4M-10.4% | $138.9M-10.9% | $149.3M+2.3% | $157.5M+19.9% | $162.4M+83.5% |
| Total Equity | $285.8M+54.7% | $262.3M+67.5% | $236.0M+63.0% | $240.3M+72.8% | $184.8M+24.2% | $156.6M-2.8% | $144.7M-16.0% | $139.1M-21.0% |
| Retained Earnings | -$302.1M+17.6% | -$302.3M+22.9% | -$320.8M+19.6% | -$314.2M+21.9% | -$366.8M+5.9% | -$391.9M-5.3% | -$399.2M-11.9% | -$402.5M-15.3% |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.
ATEX Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-Q | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.0M+165.1% | $15.5M+193.7% | -$8.3M-7.4% | $1.4M+153.0% | -$3.1M-33.0% | -$16.6M-369.6% | -$7.7M-122.9% | -$2.6M-125.4% |
| Depreciation & Amortization | $101K-18.5% | $103K+35.5% | $104K-26.8% | $133K-11.9% | $124K-30.7% | $76K-60.2% | $142K-28.3% | $151K-27.8% |
| Stock-Based Compensation | $3.3M-9.6% | N/A | N/A | N/A | $3.6M-16.4% | N/A | N/A | N/A |
| Capital Expenditures | $36K | $22K-52.2% | $9K | $0-100.0% | $0 | $46K+15.0% | $0-100.0% | $41K-78.1% |
| Free Cash Flow | $2.0M+164.0% | $15.5M+193.3% | -$8.3M-7.6% | $1.4M+152.2% | -$3.1M-33.0% | -$16.6M-372.1% | -$7.7M-122.9% | -$2.7M-126.3% |
| Investing Cash Flow | -$6.7M-152.9% | $46.1M+30.2% | -$2.3M-34.0% | -$604K+89.1% | -$2.7M+50.6% | $35.4M+1665.6% | -$1.7M+62.2% | -$5.5M-127.6% |
| Financing Cash Flow | $20.0M+3207.6% | $5.2M+2051.9% | -$10K+99.8% | -$907K-150.6% | -$642K+40.1% | -$264K+95.0% | -$4.9M+39.5% | -$362K+96.7% |
| Share Buybacks | N/A | $0-100.0% | $0-100.0% | $990K | $0-100.0% | $2.0M-67.3% | $4.4M-44.6% | $0-100.0% |
Not reported in any period shown, so not listed: Dividends Paid.
ATEX Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-Q | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -12.6% | 1013.0% | -576.0% | 3909.5% | 1585.4% | 676.5% | 449.0% | -846.6% |
| Net Margin | 12.3% | -3678.5% | -419.6% | 3449.5% | 1775.7% | 1480.8% | 492.3% | -823.1% |
| Return on Equity | 0.1%-13.6pp | -27.5%-40.6pp | -2.8%-8.1pp | 22.3%+31.4pp | 13.6%+24.1pp | 13.1%+13.3pp | 5.3%+5.1pp | -9.2%-10.4pp |
| Return on Assets | 0.1%-7.0pp | -15.5%-21.6pp | -1.6%-3.9pp | 12.7%+16.8pp | 7.0%+11.8pp | 6.2%+6.3pp | 2.4%+2.3pp | -4.0%-4.8pp |
| Current Ratio | 4.85+3.3x | 3.33+1.1x | 1.39-0.3x | 1.70-1.9x | 1.54-2.4x | 2.23-1.8x | 1.65-2.9x | 3.59-0.5x |
| Debt-to-Equity | 0.74-0.2x | 0.77-0.4x | 0.77-0.5x | 0.75-0.5x | 0.95-0.2x | 1.13+0.1x | 1.26+0.4x | 1.28+0.7x |
| Asset Turnover | 0.000.0x | 0.000.0x | 0.000.0x | 0.000.0x | 0.000.0x | 0.000.0x | 0.000.0x | 0.000.0x |
| FCF Margin | 102.6% | 791.5% | -526.5% | 90.5% | -221.4% | -1195.2% | -491.6% | -173.4% |
Not reported in any period shown, so not listed: Gross Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Anterix Inc ATEX | FY2026 | $6.5M | $91K | 1.4% | $1.6B | 43/100 |
| Wideopenwest WOW | FY2024 | $630.9M | -$58.8M | -9.3% | $445.7M | 14/100 |
| Sify Technologie SIFY | FY2026 | $474.0M | -$15.0M | -3.2% | $1.0B | 25/100 |
| Shenandoah Telecommunications SHEN | FY2025 | $357.9M | -$32.9M | -9.2% | $674.9M | 28/100 |
| Cable One Inc CABO | FY2025 | $1.5B | -$357.3M | -23.8% | $130.7M | 33/100 |
| Altice Usa ATUS | FY2025 | $8.6B | -$1.8B | -21.3% | $841.0M | 27/100 |
Where Anterix Inc Ranks
Frequently Asked Questions
What is Anterix Inc's annual revenue?
Anterix Inc (ATEX) reported $6.5M in total revenue for fiscal year 2026. This represents a 7.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Anterix Inc's revenue growing?
Anterix Inc (ATEX) revenue grew by 7.8% year-over-year, from $6.0M to $6.5M in fiscal year 2026.
Is Anterix Inc profitable?
Yes, Anterix Inc (ATEX) reported a net income of $91K in fiscal year 2026, with a net profit margin of 1.4%.
What is Anterix Inc's EBITDA?
Anterix Inc (ATEX) had EBITDA of $94.4M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.
What is Anterix Inc's net profit margin?
Anterix Inc (ATEX) had a net profit margin of 1.4% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.
What is Anterix Inc's return on equity (ROE)?
Anterix Inc (ATEX) has a return on equity of 0.0% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.
What is Anterix Inc's free cash flow?
Anterix Inc (ATEX) generated $5.5M in free cash flow during fiscal year 2026. This represents a 118.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Anterix Inc's operating cash flow?
Anterix Inc (ATEX) generated $5.5M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.
What are Anterix Inc's total assets?
Anterix Inc (ATEX) had $465.2M in total assets as of fiscal year 2026, including both current and long-term assets.
What are Anterix Inc's capital expenditures?
Anterix Inc (ATEX) invested $31K in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.
How much does Anterix Inc spend on research and development?
Anterix Inc (ATEX) invested $4.7M in research and development during fiscal year 2026.
What is Anterix Inc's current ratio?
Anterix Inc (ATEX) had a current ratio of 3.33 as of fiscal year 2026, which is generally considered healthy.
What is Anterix Inc's debt-to-equity ratio?
Anterix Inc (ATEX) had a debt-to-equity ratio of 0.77 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Anterix Inc's return on assets (ROA)?
Anterix Inc (ATEX) had a return on assets of 0.0% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
What is Anterix Inc's P/E ratio?
Anterix Inc (ATEX) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $1.6B as of Sep 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Anterix Inc's price-to-sales ratio?
Anterix Inc (ATEX) trades at 234x sales, its market capitalization divided by revenue of $7.0M revenue, trailing 12 months to June 30, 2026. The market capitalization is $1.6B as of Sep 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Anterix Inc's Altman Z-Score?
Anterix Inc (ATEX) has an Altman Z-Score of 4.85, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Anterix Inc's Piotroski F-Score?
Anterix Inc (ATEX) has a Piotroski F-Score of 5 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Anterix Inc's earnings high quality?
Anterix Inc (ATEX) reported $91K of net income while generating $5.5M in operating cash flow. The ratio between the two is outside the range this page publishes as a per-dollar figure, so both figures are given instead. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Anterix Inc?
Anterix Inc (ATEX) scores 43 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.